Iris Valdés Prado

Title: Iris Valdés Prado: Innovator in Vaccine Development

Introduction

Iris Valdés Prado is a prominent inventor based in La Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her work focuses on combating the dengue virus, a major public health concern in many tropical regions.

Latest Patents

Iris Valdés Prado holds a patent for a dengue virus vaccine composition. This innovative vaccine comprises at least one antigen based on the dengue virus (DV) capsid protein and the oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein of the same serotype. This formulation has been shown to elicit higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of these compositions has also been demonstrated in non-human primates. The vaccine can be monovalent, bivalent, or tetravalent, and is designed to induce a functional immune response to the four viral serotypes.

Career Highlights

Throughout her career, Iris Valdés Prado has worked with notable institutions such as the Centro de Ingeniería Genética y Biotecnología. Her research has focused on developing effective vaccine strategies to combat viral infections, showcasing her dedication to public health and scientific advancement.

Collaborations

Iris has collaborated with Lázaro Gil González, contributing to the advancement of vaccine research and development. Their partnership has been instrumental in the progress of innovative solutions to combat dengue virus infections.

Conclusion

Iris Valdés Prado is a trailblazer in the field of vaccine development, particularly for dengue virus. Her innovative work and dedication to biotechnology have the potential to significantly impact public health.